Freestone Grove Partners LP Makes New $1.29 Million Investment in The Cooper Companies, Inc. $COO

Key Points

• Freestone Grove Partners opened a new position in Cooper Companies worth approximately $1.29 million, purchasing 18,013 shares during the second quarter. Institutional investors and hedge funds collectively own 24.39% of the company.
• Cooper Companies exceeded quarterly expectations, reporting $1.21 in EPS versus the $1.10 consensus and $1.08 billion in revenue, up 7.9% year over year. Management provided fiscal 2026 EPS guidance of $4.58–$4.66.
• Analyst sentiment remains mixed: the stock has a consensus “Hold” rating and an average price target of $81.64, while several firms recently cut their targets even as one analyst upgraded the shares to “Buy.”

Freestone Grove Partners LP acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 18,013 shares of the medical device company's stock, valued at approximately $1,292,000.

Other institutional investors have also modified their holdings of the company. Avalon Trust Co acquired a new position in shares of Cooper Companies in the 2nd quarter valued at $25,000. Root Financial Partners LLC lifted its position in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after acquiring an additional 162 shares in the last quarter. SJS Investment Consulting Inc. lifted its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after purchasing an additional 187 shares in the last quarter. Elevation Wealth Partners LLC boosted its position in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after buying an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in Cooper Companies during the 2nd quarter valued at approximately $32,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Up 0.3%

Shares of COO stock opened at $71.17 on Friday. The stock's 50 day simple moving average is $72.56 and its 200 day simple moving average is $70.88. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a market capitalization of $13.88 billion, a price-to-earnings ratio of 60.31, a PEG ratio of 1.86 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm's revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analysts Set New Price Targets

COO has been the subject of several research reports. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $80.00 to $71.00 and set a "neutral" rating for the company in a research report on Friday, June 5th. Wells Fargo & Company reaffirmed a "sell" rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a report on Sunday, June 21st. Weiss Ratings lowered Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research note on Monday, June 8th. Finally, BNP Paribas Exane dropped their target price on shares of Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of "Hold" and an average price target of $81.64.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source